Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
about
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsPromising Therapy Candidates for Liver FibrosisHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepRole of NADPH oxidases in the redox biology of liver fibrosisNADPH oxidases in lung health and diseaseBiphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytesRole of NADPH oxidases in liver fibrosis.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosisReactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-β1 in skeletal muscle during the repair process.NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in miceFluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese miceNADPH oxidase is implicated in the pathogenesis of oxidative phosphorylation dysfunction in mice fed a high-fat diet.Exposure to fine airborne particulate matters induces hepatic fibrosis in murine models.C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease.Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.Fibrogenesis in nonalcoholic steatohepatitis.Hepatic stellate cells and innate immunity in alcoholic liver disease.Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase.Inflammation and fibrogenesis in steatohepatitis.New therapies for hepatic fibrosis.Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.NADPH Oxidases in Chronic Liver DiseasesNew Developments on the Treatment of Liver Fibrosis.Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis.Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy.Liver fibrogenesis in non-alcoholic steatohepatitis.Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis.NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation.
P2860
Q26766479-BE2D8B17-8DCF-4AD8-BB8E-CA4AB79C6C15Q26766727-40A75A52-1EAF-475F-B44F-FC02A30465C9Q26771518-DD8140AA-8D7C-4530-A7F6-681CA777E578Q26800143-646933C3-1807-4BC8-9DB0-049AA98D524AQ27027435-F6E898DA-C403-41AE-811F-C597DD5CB990Q28397804-7EAA528D-B1F4-4B4D-B6F9-643A446C06CEQ33632736-F391907D-9F0C-45AD-B7A1-7931159CD5BDQ33904328-93F0BFA7-5502-45D5-BEB3-2CB9091F62D7Q33997351-27F12AA9-DF42-4AA6-BDC4-2AAB1763454FQ34009236-DE371365-253F-4F79-A8F2-237A04715644Q34288768-519E0CEF-192D-4829-ABA5-E66F85F0CD35Q34310013-386E9A09-07E9-4199-B0D1-C716EA65A5DFQ34438060-62DE0E62-763B-40FB-8304-D6E97EE2A55DQ34860956-3112D146-6742-419D-80F7-35E6FC9926C3Q35107757-8242A165-1440-4F0D-9111-CFA3433A26BEQ35926102-631B89F7-7FF0-4513-9141-7F466CA78836Q36898694-291196D4-F191-4259-AEFE-7B1B87A5FC7AQ37213928-094E5D89-42D1-4DC3-A5F1-03E0A4848E74Q37225434-353902AE-0B02-4003-B3E8-9085E1B8B52DQ37498674-D4BF2DCD-DF72-40F2-AAFE-11543AD0C00EQ37863130-2B500D84-A039-4F95-8D9F-B4A3CE45119BQ37883935-34300733-335E-48BC-8765-2B34E0E16ACDQ37895340-E9E196B5-7AD6-4BDD-A0E5-82420CF83267Q37981867-133131E6-E543-4FC4-BAC9-3C0FDFAB36AAQ38553309-6CCACE00-755A-405D-B1A5-8564A5518B74Q38557011-FFBFD094-769A-484B-84A1-9BFBEA225AADQ38599090-5448C75A-EBEF-4713-B5DC-DA9DDEBE8D03Q38873303-A6CA07A1-E713-4685-BA7F-E79517B6FED3Q39707817-F80D3DFE-3970-459C-B362-28B65C4ECC53Q40263666-C5A67D6E-097C-48EB-90A0-FCB3C26C7495Q40966286-B54EDAAC-66EF-4B96-9DF9-EA1C453AD3C9Q42321514-95F44C5D-9576-4E0D-8965-14970F342375Q46861795-0617F543-0C09-4123-8C2A-06E665711CDFQ55287286-9AF196A8-A1E5-430A-9943-805F4E902964
P2860
Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@en
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@nl
type
label
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@en
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@nl
prefLabel
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@en
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Role and cellular source of ni ...... e oxidase in hepatic fibrosis.
@en
P2093
Antonio Benedetti
Christoph H Osterreicher
Ekihiro Seki
Johannes Kluwe
Katsumi Miyai
Luciano Torozzi
Robert F Schwabe
Samuele De Minicis
Yong-Han Paik
Yuzo Kodama
P2860
P304
P356
10.1002/HEP.23804
P407
P577
2010-10-01T00:00:00Z